Technical Analysis for AMPE - Ampio Pharmaceuticals, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Stochastic Buy Signal | Bullish | 0.00% | |
| Pocket Pivot | Bullish Swing Setup | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| New 52 Week Closing Low | Bearish | 450.00% | |
| Expansion Breakdown | Bearish Swing Setup | 450.00% | |
| Stochastic Buy Signal | Bullish | 450.00% | |
| Narrow Range Bar | Range Contraction | 450.00% | |
| New 52 Week Low | Weakness | 450.00% |
Get a Trading Sidekick!
- Earnings date: 11/12/2024
Ampio Pharmaceuticals, Inc. Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, together with its subsidiaries, engages in the discovery and development of pharmaceutical drugs and diagnostic products to identify, treat, and prevent metabolic disorders, eye diseases, kidney diseases, acute and chronic inflammation diseases, and male sexual dysfunction. Its products include Ampion, a non-steroidal anti-inflammatory biologic to treat inflammatory conditions and autoimmune diseases; Optina, an orally administered danazol for the treatment of diabetic macular edema; Vasaloc for the treatment of diabetic nephropathy; and Zertane, an oral drug for treating male sexual dysfunction to premature ejaculation, which is under Phase III clinical trial. The company is also developing a handheld oxidation-reduction potential diagnostic device for use at home or in healthcare facilities that will measure the oxidants/antioxidant balances in human blood and plasma; and methylphenidate derivatives for cancer, which are in pre-clinical development. Ampio Pharmaceuticals, Inc. is headquartered in Greenwood Village, Colorado.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancer Life Sciences Diabetes Autoimmune Disease Clinical Development Eye Inflammation Healthcare Facilities Kidney Disease Diagnostic Products Dysfunction Eye Diseases Diabetic Retinopathy Macular Edema Diabetic Macular Edema Metabolic Disorders Diabetic Nephropathy Methylphenidate Antioxidant Inflammatory Conditions Inflammation Diseases Male Sexual Dysfunction Sexual Dysfunction
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 7.47 |
| 52 Week Low | 0.0004 |
| Average Volume | 2,431 |
| 200-Day Moving Average | 1.29 |
| 50-Day Moving Average | 0.11 |
| 20-Day Moving Average | 0.01 |
| 10-Day Moving Average | 0.00 |
| Average True Range | 0.03 |
| RSI (14) | 39.39 |
| ADX | 45.72 |
| +DI | 39.60 |
| -DI | 16.13 |
| Chandelier Exit (Long, 3 ATRs) | 0.37 |
| Chandelier Exit (Short, 3 ATRs) | 0.08 |
| Upper Bollinger Bands | 0.07 |
| Lower Bollinger Band | -0.04 |
| Percent B (%b) | 0.39 |
| BandWidth | 749.66 |
| MACD Line | -0.04 |
| MACD Signal Line | -0.04 |
| MACD Histogram | 0.0058 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.00 | ||||
| Resistance 3 (R3) | 0.00 | 0.00 | 0.00 | ||
| Resistance 2 (R2) | 0.00 | 0.00 | 0.00 | 0.00 | |
| Resistance 1 (R1) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pivot Point | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Support 1 (S1) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Support 2 (S2) | 0.00 | 0.00 | 0.00 | 0.00 | |
| Support 3 (S3) | 0.00 | 0.00 | 0.00 | ||
| Support 4 (S4) | 0.00 |
